Purchase Order 36C77019P0579
- Not listed
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order contract to Tri-Pharma, Inc., a minority-owned small disadvantaged business, to provide pharmaceuticals. The $698,425.00 contract has a completion date of June 3, 2019 and does not include a set-aside designation. Tri-Pharma is a specialty pharmaceutical wholesaler that has provided products such as RYDAPT tablets, fludarabine, and ranitidine to VA medical centers and the NIH Clinical...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The $698,075.00 contract does not have a set-aside designation and was completed on June 3, 2019. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided various pharmaceutical products and medical supplies to the VA and Department of Health and Human Services under previous...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The contract has a potential value of $698,075.00 and a completion date of June 3, 2019. Tri-Pharma has previously provided pharmaceutical products and personal protective equipment to various government agencies, including the VA and the Department of Health and Human...
- This federal contract award to Tri-Pharma, Inc. (doing business as Tri-Pharma Inc.) was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The $123,374.00 firm-fixed-price purchase order, which has no set-aside designation, is for IV solutions. The contract supports the Hurricane Harvey 2017 National Interest Action. Tri-Pharma is a minority-owned, self-certified small disadvantaged business that specializes in sourcing and...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Tri-Pharma, Inc., a minority-owned, Hispanic American-owned small disadvantaged business corporation. The $15,500 contract is for the delivery of pharmaceutical and medical supply products, including items like SANDOSTATIN, RYDAPT, fludarabine, ranitidine, and personal protective equipment such as N95 masks, surgical masks, and disinfectant wipes. The...
- The U.S. Department of Health and Human Services National Institutes of Health Clinical Center awarded a $134,371.05 firm-fixed-price purchase order contract to Tri-Pharma, Inc., a minority-owned, small disadvantaged business. The contract, which has no set-aside designation, is for the delivery of pharmaceutical products such as RYDAPT tablets, fludarabine, and ranitidine to the NIH Clinical Center. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided medical supplies and personal...
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business. The $135,790.00 firm-fixed-price purchase order is for the supply of METREX CAVIWIPE products. The contract has a completion date of August 31, 2020 and was awarded on July 9, 2020 in support of the Coronavirus COVID-19 national interest action. Tri-Pharma is a specialty pharmaceutical wholesaler that has previously...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business. The contract, valued at $1,326,625.26, is for the supply of the pharmaceutical drug pantoprazole to all VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The contract does not have a set-aside designation and has an ultimate completion date of February 26, 2016. Tri-Pharma, Inc. is a Subchapter S...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price purchase order to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of Buspirone 10mg tablets to the VA's Consolidated Mail Out-Patient Pharmacy (CMOP) network. The $750,400 contract has a completion date of June 11, 2019. The contract was a full and open competition with no set-aside designation. According to the information provided, Tri-Pharma is a specialty...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Tri-Pharma, Inc., a minority-owned, small disadvantaged business, for the supply of 3,128 units of the pharmaceutical drug BUSPIRONE HCL 15MG TAB. The contract has a firm-fixed price of $547,400.00 and a completion date of June 17, 2019. The contract was a full and open competition with no set-aside. Tri-Pharma has a history of providing pharmaceutical and medical supply products to the VA...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, to provide pharmaceutical products. The $244,500.00 contract has a performance period ending on March 25, 2019 and does not have a set-aside designation. Tri-Pharma has provided pharmaceuticals such as RYDAPT tablets, fludarabine, and ranitidine to VA Medical Centers and the NIH Clinical Center under previous prime contracts. The company has also delivered personal protective equipment to VA Health Networks in support of COVID-19 response efforts, and received awards from the Indian Health Service and the HHS Office of the Assistant Secretary for Administration. Additionally, Tri-Pharma holds a $250,000 Blanket Purchase Agreement with the Department of the Army's Installation Management Command Northeast Region to provide PPE and cleaning supplies to support COVID-19 response and routine facility maintenance.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
770 Nat / Rx Buspirone II / EMERG - sole source 770-A90038 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Award Notice 1/1 | 3/24/19, 2:27 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 3/25/19 | |
| P00001 | Other Administrative Action | $0 | 3/19/19 | |
| Not listed | Not listed | $244.5k | 2/27/19 |